TERT and neuroblastoma: Our findings show that SCNAs adjust the regulatory landscape of neuroblastoma toward dysregulation of key cancer pathways and that copy-number gains effectively upregulate TERT in tumors with CTM (Figure 3F), with highest telomerase expression found in tumors with both TERT activation and copy-number gains.